Four weeks of daily Hericium erinaceus supplementation produced no statistically significant changes in executive function or plasma BDNF in healthy adults, but small-to-moderate effect sizes suggest 'a promising signal for LM supplementation that warrants further investigation in larger and longer-term randomized double-blind placebo-controlled studies.'
Key Findings
Results
No statistically significant differences were observed in executive function or plasma BDNF following four weeks of lion's mane supplementation.
All comparisons yielded p > 0.05
Sample size was small (n = 10 healthy adults aged 18-55 years)
Paired-samples t-tests were used to assess pre-to-post changes
Study duration was 28 days of daily supplementation
Results
Small-to-moderate effect sizes were observed for flanker inhibitory control and attention following lion's mane supplementation.
Cohen's d = 0.48 for the NIH Toolbox Flanker Inhibitory Control and Attention Test
This represents a small-to-moderate effect size
The flanker test assesses attentional control and inhibitory control
Changes were in the direction of improvement from baseline
Results
A small effect size was observed for the Dimensional Change Card Sort (DCCS) test following lion's mane supplementation.
Cohen's d = 0.25 for the DCCS test
The DCCS test measures cognitive flexibility as a component of executive function
The effect was in the direction of modest improvement from baseline
The change did not reach statistical significance (p > 0.05)
Results
A small effect size was observed for circulating plasma BDNF following lion's mane supplementation.
Cohen's d = 0.31 for plasma BDNF concentrations
Plasma BDNF was measured using a quantitative ELISA
The effect was described as a 'modest increase' from baseline
The change did not reach statistical significance (p > 0.05)
Conclusions
Lion's mane supplementation was reported to be safe and well tolerated in healthy adults over the 28-day study period.
The supplement was a certified organic lion's mane product composed of mycelial biomass and fruiting body
The daily dose was 2 g/day consumed for 28 days
No adverse safety findings were reported within the confines of this study
Participants were healthy adults aged 18-55 years (n = 10)
Methods
The study used the NIH Toolbox Flanker Inhibitory Control and Attention Test and the DCCS test to assess executive function as primary cognitive outcomes.
Executive function was characterized as supporting 'goal-directed behavior, attentional control, and cognitive flexibility'
These processes were described as 'sensitive to aging and lifestyle factors'
Assessments were conducted at baseline (pre) and after 28 days (post)
Effect sizes were calculated using Cohen's d in addition to significance testing
Background
Hericium erinaceus contains bioactive compounds hypothesized to stimulate neurotrophins such as BDNF, providing the mechanistic rationale for this study.
Lion's mane is described as an edible mushroom with bioactive compounds
The proposed mechanism involves stimulation of neurotrophins, specifically brain-derived neurotrophic factor (BDNF)
BDNF stimulation was the basis for hypothesizing potential cognitive benefits
The supplement used contained both mycelial biomass and fruiting body components
What This Means
This research suggests that taking 2 grams per day of a lion's mane mushroom supplement for four weeks did not produce statistically significant improvements in cognitive function or levels of a brain growth protein called BDNF (brain-derived neurotrophic factor) in a small group of 10 healthy adults. The study tested two aspects of executive function — the ability to focus attention while ignoring distractions, and the ability to mentally switch between different rules — using standardized tests from the NIH Toolbox.
However, the study found small-to-moderate 'effect sizes,' which are a statistical measure of how large a change occurred regardless of whether it reached significance. The effect sizes ranged from 0.25 to 0.48, suggesting there were modest trends toward improvement in cognitive scores and BDNF levels, even though the sample was too small to confirm these as statistically reliable findings. The supplement was also reported to be safe and well tolerated by all participants over the 28-day period.
This research suggests that lion's mane supplementation may show a 'promising signal' worth exploring further, but the very small sample size (10 people) and short duration (four weeks) mean strong conclusions cannot be drawn. The authors call for larger, longer studies using a randomized, double-blind, placebo-controlled design — the gold standard for clinical research — to determine whether these trends represent genuine cognitive benefits of lion's mane supplementation.
Check Your Own Numbers
Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.
Evans C, Kalman D, Goodrich J, Burgess V, Tartar J, Jiannine L, et al.. (2026). A Pilot Proof-of-Concept Study to Evaluate the Physiological and Cognitive Impacts of Hericium erinaceus on Healthy Adults.. Nutrients. https://doi.org/10.3390/nu18193177